LNSR - NASDAQ

LENSAR, Inc.

LNSR·NASDAQ

$5.74

-2.0%

HealthcareMedical - Devices

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$69.48M

EPS-2.8700

P/E Ratio-2.00

Earnings Date08/06/2026

71.43M

Assets

3Y+28.0%

5Y-10.0%

10Y+147.0%

97.45M

Total Liabilities

105%

3Y+603.0%

5Y+718.0%

10Y+97.0%

-26.02M

Total Equity

-240%

3Y-162.0%

5Y-139.0%

10Y+27.0%

LENSAR, Inc. Funding & Solvency Profile

LNSR · NASDAQ

Current Assets

Cash & Cash Equivalents12.97M

Net Receivables6.38M

Inventory21.52M

Other Current Assets896.00K

Total Current Assets47 M

Non-Current Assets

Property, Plant & Equipment505.00K

Goodwill & Intangible Assets5.19M

Long-Term Investments0.00

Other Non-Current Assets18.96M

Total Non-Current Assets19 M

Total Assets

71.43M

Financial Health Analysis

Current Ratio

1.15x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Working Capital

6 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

65% Current

Asset-light business model with high liquidity. Majority of assets are easily convertible to cash.

LENSAR, Inc. Balance Sheet

LNSR • NASDAQ

LENSAR, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	13M	16.3M	20.6M	14.7M	31.6M	40.6M	4.6M	3.3M
Short-Term Investments	5M	6.2M	3.4M	0.0	0.0	0.0	0.0	0.0
Cash & Short-Term Investments	18M	22.5M	24.1M	14.7M	31.6M	40.6M	4.6M	3.3M
Net Receivables	6.4M	6.5M	4.3M	6.2M	5M	2.5M	3.9M	3.3M
Accounts Receivables	6.4M	6.1M	4.3M	6.2M	4.6M	2.5M	3.9M	3.3M
Other Receivables	0.0	395K	0.0	0.0	350K	0.0	0.0	0.0
Inventory	21.5M	11.4M	15.7M	11.7M	6.5M	13.5M	8.1M	4.1M
Prepaids	0.0	0.0	0.0	0.0	1.7M	1.9M	618K	567K
Other Current Assets	896K	1.6M	2.4M	1.1M	0.0	0.0	0.0	472K
Total Current Assets	46.8M	42M	46.4M	33.7M	44.8M	58.4M	17.2M	11.7M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	505K	664K	10.3M	6.9M	7.4M	4.4M	2.2M	3.6M
Intangible Assets	5.2M	6.1M	11M	12.1M	10.9M	12.1M	13.4M	12.3M
Goodwill & Intangible Assets	5.2M	6.1M	11M	12.1M	10.9M	12.1M	13.4M	12.3M
Long-Term Investments	0.0	1.2M	492K	442K	0.0	0.0	827K	753K
Tax Assets	0.0	0.0	0.0	-442K	0.0	0.0	-827K	0.0
Other Non-Current Assets	19M	16.4M	1.3M	3.1M	3.3M	4.2M	1.8M	476K
Total Non-Current Assets	24.7M	24.3M	23.1M	22.1M	21.7M	20.7M	17.4M	17.1M
Total Assets	71.4M	66.3M	69.6M	55.8M	66.5M	79.1M	34.5M	28.9M
LIABILITIES
CURRENT LIABILITIES
Total Payables	19M	6M	4M	5.4M	2.7M	2.5M	1.6M	1.4M
Accounts Payable	19M	6M	4M	5.4M	2.7M	2.5M	1.6M	1.4M
Accrued Expenses	2.7M	1.8M	1.7M	1.2M	1.2M	1.6M	4M	3.6M
Short Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	555K	653K
Capital Lease Obligations (Current)	747K	524K	559K	531K	512K	493K	555K	0.0
Deferred Revenue	3.1M	1.7M	1.3M	768K	904K	923K	777K	871K
Other Current Liabilities	15.1M	5M	4M	3.5M	3.4M	3M	393K	2M
Total Current Liabilities	40.6M	15M	11.6M	11.4M	8.7M	8.5M	7.8M	7.7M
NON-CURRENT LIABILITIES
Long Term Debt	0.0	0.0	0.0	0.0	0.0	0.0	56.6M	41.2M
Other Non-Current Liabilities	54.9M	30.6M	9M	167K	69K	129K	310K	479K
Total Non-Current Liabilities	56.9M	32.6M	10.8M	2.4M	2.9M	3.4M	57.3M	41.7M
Capital Lease Obligations	2.7M	2.6M	2.3M	2.8M	3.3M	3.8M	333K	0.0
Total Liabilities	97.4M	47.7M	22.4M	13.9M	11.6M	11.9M	65.1M	49.4M
SHAREHOLDERS' EQUITY
Preferred Stock	0.0	13.8M	13.7M	0.0	0.0	0.0	38.2M	23.4M
Common Stock	120K	116K	113K	111K	110K	109K	11K	96K
Additional Paid-In Capital	151.4M	148M	145.2M	139.4M	132.4M	125.1M	7.6M	3M
Retained Earnings	-177.6M	-143.3M	-111.9M	-97.5M	-77.6M	-58M	-38.2M	-23.5M
Accumulated Other Comprehensive Income/Loss	4K	6K	4K	0.0	0.0	0.0	-38.2M	-23.5M
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96K
Total Stockholders' Equity	-26M	18.6M	47.2M	42M	54.9M	67.2M	-30.6M	-20.5M
Total Equity	-26M	18.6M	47.2M	42M	54.9M	67.2M	-30.6M	-20.5M
SUMMARY
Total Liabilities & Equity	71.4M	66.3M	69.6M	55.8M	66.5M	79.1M	34.5M	28.9M
Total Investments	5M	7.4M	3.9M	442K	0.0	0.0	827K	753K
Total Debt	2.7M	2.6M	2.3M	2.8M	3.3M	3.8M	20.5M	41.2M
Net Debt	-10.2M	-13.6M	-18.3M	-11.9M	-28.3M	-36.8M	15.9M	37.9M
Shares Outstanding	11,934,784	11,934,784	11,934,784	11,934,784	11,934,784	11,934,784	11,934,784	11,934,784

SEC Filings

LNSR - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 29, 2026	May 25, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 08, 2026	May 08, 2026	2026	View Filing
10-K/A 10-K/A 2025 FY (Amended) FY	April 30, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	April 15, 2026	April 10, 2026	2026	View Filing
10-K 10-K 2025 FY FY	March 31, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	March 31, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 17, 2026	March 16, 2026	2026	View Filing
8-K/A 8-K/A 2026 (Amended) N/A	March 13, 2026	March 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 12, 2026	March 12, 2026	2026	View Filing

Showing 1 to 10 of 94 filings

Related Guides

Blog Categories

Continue your LNSR research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.